Physician profile
Tun Lin
NPI 1134195738
$18,554.60
in general payments reported to CMS, 2019-2025
46 companies · $2,561 in 2025
The $2,561 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,400 · 2020: $1,597 · 2021: $2,294 · 2022: $2,286 · 2023: $2,611 · 2024: $2,806 · 2025: $2,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,978.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $3,003.65 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,860.01 | 2019-2025 | |
| Novo Nordisk INC | $1,270.99 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $1,219.10 | 2019-2025 | Evenity, Prolia, Otezla |
| Glaxosmithkline, LLC. | $1,192.09 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $1,118.60 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $870.05 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Lilly USA, LLC | $845.85 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $737.39 | 2019-2025 | Jardiance, Synjardy |
| Merck Sharp & Dohme LLC | $725.77 | 2019-2023 | |
| Pfizer INC. | $639.01 | 2019-2025 | |
| Gilead Sciences, INC. | $523.25 | 2019-2025 | |
| Exact Sciences Corporation | $404.31 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $358.32 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $331.55 | 2020-2024 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tun Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.